MACKENZIE FINANCIAL CORP - SAGE THERAPEUTICS INC ownership

SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 214 filers reported holding SAGE THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.73 and the average weighting 0.1%.

Quarter-by-quarter ownership
MACKENZIE FINANCIAL CORP ownership history of SAGE THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$237,237
+11.9%
4,925
-2.6%
0.00%
Q1 2023$212,066
+6.0%
5,054
-3.7%
0.00%
Q4 2022$200,121
-5.6%
5,247
-3.1%
0.00%
Q3 2022$212,000
-87.0%
5,416
-89.0%
0.00%
-100.0%
Q1 2022$1,627,000
-23.9%
49,146
-2.2%
0.00%
-33.3%
Q4 2021$2,137,000
-1.5%
50,246
+2.7%
0.00%0.0%
Q3 2021$2,169,000
-3.5%
48,946
+23.8%
0.00%0.0%
Q2 2021$2,247,000
+29.7%
39,546
+70.9%
0.00%0.0%
Q1 2021$1,732,000
+179.8%
23,146
+170.0%
0.00%
+50.0%
Q4 2019$619,000
-48.5%
8,573
+0.1%
0.00%
-33.3%
Q3 2019$1,202,000
-22.7%
8,565
+0.8%
0.00%
-25.0%
Q2 2019$1,555,000
+50.5%
8,494
+30.7%
0.00%
+100.0%
Q1 2019$1,033,000
+289.8%
6,497
+135.1%
0.00%
+100.0%
Q4 2018$265,000
-89.1%
2,763
-83.9%
0.00%
-83.3%
Q3 2018$2,426,000
-1.2%
17,175
+9.5%
0.01%0.0%
Q2 2018$2,456,000
+622.4%
15,689
+642.5%
0.01%
+500.0%
Q1 2018$340,0002,1130.00%
Other shareholders
SAGE THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
RTW INVESTMENTS, LP 5,149,482$105,976,3402.24%
Palo Alto Investors LP 1,005,776$20,698,8701.96%
Boxer Capital, LLC 1,094,000$22,514,5201.20%
Bellevue Group AG 3,513,351$72,304,7641.16%
PDT Partners, LLC 181,625$3,737,8430.47%
EASTERLY INVESTMENT PARTNERS LLC 195,643$4,026,3330.44%
Harvest Investment Services, LLC 30,302$623,6150.40%
Simplify Asset Management Inc. 120,030$2,470,2170.28%
SAMLYN CAPITAL, LLC 739,867$15,226,4630.25%
CAXTON ASSOCIATES LP 68,035$1,400,1600.19%
View complete list of SAGE THERAPEUTICS INC shareholders